Nanofiber technology has emerged as a transformative platform in the realm of cancer therapeutics, bridging the disciplines of polymer chemistry, materials science, and biomedical engineering. This editorial highlight the multifaceted roles nanofibers play in cancer management, emphasizing how chemistry-driven design enables targeted, responsive, and sustained drug delivery systems. The editorial explores the application of nanofiber systems across diverse cancer types including brain, breast, lung, liver, colorectal, and gynaecological cancers showcasing their adaptability to organ-specific challenges and tumor microenvironments. Despite significant advancements, challenges related to scalability, regulatory approval, long-term safety, and cost-effectiveness remain.
Keywords: Nanofiber, Polymers, Drug delivery, Targeted delivery, Oncology.